-
2
-
-
0028670388
-
CO2, argon, and pulsed dye laser treatment of angiofibromas
-
Boixeda P, Sanchez-Miralles E, Azana JM, et al. CO2, argon, and pulsed dye laser treatment of angiofibromas. J Dermatol Surg Oncol. 1994 ; 20: 808-812
-
(1994)
J Dermatol Surg Oncol
, vol.20
, pp. 808-812
-
-
Boixeda, P.1
Sanchez-Miralles, E.2
Azana, J.M.3
-
3
-
-
81055144948
-
Multiple facial angiofibromas treated with high-frequency equipment
-
Gomes AA, Gomes YV, Lima FB, et al. Multiple facial angiofibromas treated with high-frequency equipment. An Bras Dermatol. 2011 ; 86: S186 - S189
-
(2011)
An Bras Dermatol
, vol.86
-
-
Gomes, A.A.1
Gomes, Y.V.2
Lima, F.B.3
-
4
-
-
33749011421
-
Treatment of facial angiofibroma of tuberous sclerosis using cultured epithelial autografts
-
Hori K, Soejima K, Nozaki M, et al. Treatment of facial angiofibroma of tuberous sclerosis using cultured epithelial autografts. Ann Plast Surg. 2006 ; 57: 415-417
-
(2006)
Ann Plast Surg
, vol.57
, pp. 415-417
-
-
Hori, K.1
Soejima, K.2
Nozaki, M.3
-
5
-
-
67649710762
-
Facial angiofibromas of tuberous sclerosis: Successful treatment with podophyllin
-
Turkmen M, Ertam I, Unal I, et al. Facial angiofibromas of tuberous sclerosis: successful treatment with podophyllin. J Eur Acad Dermatol Venereol. 2009 ; 23: 713-714
-
(2009)
J Eur Acad Dermatol Venereol
, vol.23
, pp. 713-714
-
-
Turkmen, M.1
Ertam, I.2
Unal, I.3
-
6
-
-
77954403911
-
New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis
-
Weiss ET, Geronemus RG. New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis. Lasers Surg Med. 2010 ; 42: 357-360
-
(2010)
Lasers Surg Med
, vol.42
, pp. 357-360
-
-
Weiss, E.T.1
Geronemus, R.G.2
-
7
-
-
47549093135
-
The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis
-
Hofbauer GF, Marcollo-Pini A, Corsenca A, et al. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis. Br J Dermatol. 2008 ; 159: 473-475
-
(2008)
Br J Dermatol
, vol.159
, pp. 473-475
-
-
Hofbauer, G.F.1
Marcollo-Pini, A.2
Corsenca, A.3
-
8
-
-
84856014473
-
Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin
-
Kaufman McNamara E, Curtis AR, Fleischer AB. Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin. J Dermatolog Treat. 2012 ; 23: 46-48
-
(2012)
J Dermatolog Treat
, vol.23
, pp. 46-48
-
-
Kaufman McNamara, E.1
Curtis, A.R.2
Fleischer, A.B.3
-
9
-
-
77958178123
-
Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient
-
Micozkadioglu H, Koc Z, Ozelsancak R, et al. Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient. Ren Fail. 2010 ; 32: 1233-1236
-
(2010)
Ren Fail
, vol.32
, pp. 1233-1236
-
-
Micozkadioglu, H.1
Koc, Z.2
Ozelsancak, R.3
-
10
-
-
80053078020
-
Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: Optimizing a treatment protocol
-
DeKlotz CM, Ogram AE, Singh S, et al. Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: optimizing a treatment protocol. Arch Dermatol. 2011 ; 147: 1116-1117
-
(2011)
Arch Dermatol
, vol.147
, pp. 1116-1117
-
-
Deklotz, C.M.1
Ogram, A.E.2
Singh, S.3
-
11
-
-
84856956808
-
Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: A pilot study of four patients
-
Foster RS, Bint LJ, Halbert AR. Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients. Australas J Dermatol. 2012 ; 53: 52-56
-
(2012)
Australas J Dermatol
, vol.53
, pp. 52-56
-
-
Foster, R.S.1
Bint, L.J.2
Halbert, A.R.3
-
12
-
-
77954830298
-
Topical rapamycin: A novel approach to facial angiofibromas in tuberous sclerosis
-
Haemel AK, O'Brian AL, Teng JM. Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis. Arch Dermatol. 2010 ; 146: 715-718
-
(2010)
Arch Dermatol
, vol.146
, pp. 715-718
-
-
Haemel, A.K.1
O'Brian, A.L.2
Teng, J.M.3
-
13
-
-
84865839005
-
Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: A double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin
-
Koenig MK, Hebert AA, Roberson J, et al. Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin. Drugs R D. 2012 ; 12: 121-126
-
(2012)
Drugs R D
, vol.12
, pp. 121-126
-
-
Koenig, M.K.1
Hebert, A.A.2
Roberson, J.3
-
14
-
-
80053550251
-
Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1)) in two patients with tuberous sclerosis
-
Mutizwa MM, Berk DR, Anadkat MJ. Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1)) in two patients with tuberous sclerosis. Br J Dermatol. 2011 ; 165: 922-923
-
(2011)
Br J Dermatol
, vol.165
, pp. 922-923
-
-
Mutizwa, M.M.1
Berk, D.R.2
Anadkat, M.J.3
-
15
-
-
84856546231
-
Facial angiofibromas treated with topical rapamycin: An excellent choice with fast response
-
Truchuelo T, Diaz-Ley B, Rios L, et al. Facial angiofibromas treated with topical rapamycin: an excellent choice with fast response. Dermatol Online J. 2012 ; 18: 15
-
(2012)
Dermatol Online J
, vol.18
, pp. 15
-
-
Truchuelo, T.1
Diaz-Ley, B.2
Rios, L.3
-
16
-
-
80053517662
-
A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): A pilot study of nine Japanese patients with TSC of different disease severity
-
Wataya-Kaneda M, Tanaka M, Nakamura A, et al. A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity. Br J Dermatol. 2011 ; 165: 912-916
-
(2011)
Br J Dermatol
, vol.165
, pp. 912-916
-
-
Wataya-Kaneda, M.1
Tanaka, M.2
Nakamura, A.3
|